Speaking at the Medicines for Europe Annual Conference, Michal Nitka, SVP head generics Europe & global head OTC at Teva Pharmaceuticals, highlights the essential role of a resilient, competitive, and environmentally sustainable pharma industry.
After Cellular Origins announced its latest collaboration with Johnson & Johnson, Olivia Friett spoke to Edwin Stone, CEO, Cellular Origins about the collab and the future of mobile robotics.
Enhanced Genomics, a biotechnology company, has announced a strategic partnership with The ALBORADA Drug Discovery Institute at the University of Cambridge.
Mario Toubes-Rodrigo, global applications leader, H.E.L Group shares how high pressure bioreactors can transform fermentation for a sustainable tomorrow.
OutSee has announced it has secured £1.8M in seed funding, led by Ahren Innovation Capital and with additional investment from Kadmos Capital, Empirical Ventures and Panacea Ventures.
INTEGRA Biosciences’ liquid handling solutions and pipette automation software are helping 3T Biosciences to enhance the reproducibility and productivity of its pipetting workflows, accelerating the discovery of novel cancer targets and therapeutics.
Joel Eichmann, co-founder & managing director of Green Elephant Biotech explores the integration of sustainable alternatives to fossil fuel-based plastics.
